1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
These authors contributed equally to this manuscript.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Liver Injury/Regeneration
You have full text access to this OnlineOpen article
Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers†‡
Article first published online: 17 DEC 2010
DOI: 10.1002/hep.24087
Copyright © 2010 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Moniaux, N., Song, H., Darnaud, M., Garbin, K., Gigou, M., Mitchell, C., Samuel, D., Jamot, L., Amouyal, P., Amouyal, G., Bréchot, C. and Faivre, J. (2011), Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers. Hepatology, 53: 618–627. doi: 10.1002/hep.24087
- †
Potential conflict of interest: Nicolas Moniaux, Haiyan Song, Marion Darnaud, Kévin Garbin, Michelle Gigou, Claudia Mitchell, and Didier Samuel have no potential conflict of interest. Laure Jamot is an employee of Alfact Innovation. Paul Amouyal is Chairman of Alfact Innovation. Gilles Amouyal is CEO of Alfact Innovation. Christian Brechot is Vice-President at Mérieux Alliance. Jamila Faivre is a scientific consultant to Alfact Innovation.
- ‡
J.F. received grant support from the Agence Nationale pour la Recherche (ANR-05-EMPB-005-02 and RPV07137LS), the Fondation de l'Avenir pour la Recherche Médicale Appliquée (ET7-473), the Association Française pour l'Etude du Foie (RAK08120LLA), and the Programme National de Recherche en Hépato-Gastroentérologie Inserm/AFEF (ASE07127LSA). N.M. was supported by grants from the Institut National de la Santé et la Recherche Médicale (INSERM) and the Institut National contre le Cancer (INCA).
- §
These authors contributed equally to this manuscript.
- ¶
fax: (33) 1 45 59 60 80
Publication History
- Issue published online: 27 JAN 2011
- Article first published online: 17 DEC 2010
- Accepted manuscript online: 19 NOV 2010 12:06PM EST
- Manuscript Accepted: 9 NOV 2010
- Manuscript Received: 30 JUL 2010
References
- 1, . Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6: 542-553.
- 2, . TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 2006; 20: 1589-1598.
- 3, , , , , , et al. Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol 2003; 39: 765-772.
- 4, , , , , , et al. Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 2003; 125: 192-201.
- 5, , , , , , et al. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med 2004; 10: 602-609.
- 6, , , , , , et al. HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice. HEPATOLOGY 2005; 42: 618-626.
- 7, , , , , , et al. Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice. HEPATOLOGY 2006; 44: 1452-1464.
- 8, , , , , , et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-864, 864.
- 9, , , , , , et al. Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut 2007; 56: 1091-1097.
- 10, , , , , , et al. HIP/PAP stimulates liver regeneration after partial hepatectomy and combines mitogenic and anti-apoptotic functions through the PKA signaling pathway. FASEB J 2003; 17: 1441-1450.
- 11, , , , , , et al. Reg-2 is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF survival pathway. Nat Cell Biol 2000; 2: 906-914.
- 12, , , , , , et al. Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology 2000; 119: 816-828.
- 13, , , , , , et al. Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes. HEPATOLOGY 2008; 48: 1942-1953.
- 14, , , , , . Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120: 649-661.
- 15, , , , , , et al. Caspase activation is associated with spontaneous recovery from acute liver failure. HEPATOLOGY 2008; 47: 1624-1633.
- 16, , , , . Oral administration of insulin receptor-interacting lectins leads to an enhancement in the hematopoietic stem and progenitor cell pool of mice. Stem Cells Dev 2010; 19: 163-174.
- 17, , , , , , et al. Crystallization and preliminary crystallographic study of HIP/PAP, a human C-lectin overexpressed in primary liver cancers. Acta Crystallogr D Biol Crystallogr 1999; 55: 1487-1489.